Assessment of Aminopyrine Metabolism in Man by Breath Analysis after Oral Administration of14C-Aminopyrine
- 26 December 1974
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 291 (26) , 1384-1388
- https://doi.org/10.1056/nejm197412262912605
Abstract
To determine whether hepatic drug metabolism might be conveniently assessed by a breath analysis technic, 4-dimethyl-14C-amino-antipyrine (aminopyrine) was administered orally to healthy ambulant and nonambulant volunteers and to patients with portal cirrhosis; some of the volunteers were restudied after pretreatment with either phenobarbital or disulfiram. 14CO2 output was estimated semiquantitatively from interval breath samples. Aminopyrine metabolic clearance rate and 12-hour breath 14CO2 output in the healthy volunteers studied before and after drug pretreatment correlated highly(r = 0.91). The metabolic clearance rate was 46 ± 7 ml per minute (mean ± S.E.) in the patients with portal cirrhosis, and 122 ± 20 ml per minute in the healthy controls (p < 0.01). Twelve-hour breath 14CO2 output was 13.8 ± 1.5 per cent in the patients with portal cirrhosis, and 32.6 ± 2.3 per cent in the nonambulant controls (p < 0.01). The data suggest that in vivo breath analysis after administration of 14C-aminopyrine provides useful information about hepatic drug metabolism in health and disease. (N Engl J Med 291:1384–1388, 1974)Keywords
This publication has 25 references indexed in Scilit:
- Clearance of Antipyrine‐Dependence of Quantitative Liver FunctionEuropean Journal of Clinical Investigation, 1974
- Determinants of serum antipyrine half-lives in patients with liver diseaseGut, 1973
- DRUG‐INDUCED AGRANULOCYTOSIS, WITH SPECIAL REFERENCE TO AMINOPHENAZONEActa Medica Scandinavica, 1972
- Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver diseaseGut, 1972
- Breath test for altered bile-acid metabolismThe Lancet, 1971
- INHIBITION OF DRUG METABOLISM BY LEVODOPA IN COMBINATION WITH A DOPA-DECARBOXYLASE INHIBITORThe Lancet, 1971
- Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in manJournal of Clinical Investigation, 1969
- PHENYLBUTAZONE AND ISONIAZID METABOLISM IN PATIENTS WITH LIVER DISEASE IN RELATION TO PREVIOUS DRUG THERAPYThe Lancet, 1968
- PERSISTENCE OF ANTIBIOTICS IN BLOOD OF PATIENTS WITH ACUTE RENAL FAILURE. II. CHLORAMPHENICOL AND ITS METABOLIC PRODUCTS IN THE BLOOD OF PATIENTS WITH SEVERE RENAL DISEASE OR HEPATIC CIRRHOSIS*†Journal of Clinical Investigation, 1959
- Stimulatory Effect of Foreign Compounds on Ascorbic Acid Biosynthesis and on Drug-Metabolizing EnzymesNature, 1959